Scientology billionaire Bob Duggan and his pharmaceutical company Summit Therapeutics are now facing a tsunami of legal threats due to allegations of serious misconduct. When fourteen plaintiffs’ firms across thirty-nine months independently […]
May 1, 2026 — 8:30 AM Los Angeles News Desk Update. Summit Therapeutics filed its Q1 2026 Form 10-Q with the SEC at 5:00 PM Eastern on April 30, 2026 — one […]
Chart: May 1, 2026 – Market Chameleon. Summit Therapeutics after-hours volume spikes to 34.3x as algorithmic material event detection defeats sophisticated disclosure engineering. May 1, 2026 – 1:00 AM Los Angeles News […]
Bob Duggan’s Summit Therapeutics goes off the cliff at end of the trading day on April 30, 2026 Bob Duggan, the reclusive Scientology OT8 and controlling shareholder of Summit Therapeutics, absorbed roughly […]
On Tuesday, April 21, 2026, the London Gazette published a First Gazette Notice initiating the strike-off of Summit (Oxford) Limited, United Kingdom company number 04636431. The notice states that unless cause is […]
MarketScreener Chart: The financial chart is devastating. We think Bob Duggan is not running a pharmaceutical company. Rather, the publicly available information indicates that that he is managing a controlled demolition while extracting […]
On a recent episode of The Iced Coffee Hour — a YouTube channel with 1.57 million subscribers — Grant Cardone made two significant admissions about the financial condition of his hybrid real […]
Ex-Scientologist Sea Org member and social media influencer Aaron Smith-Levin was found guilty of one count of misdemeanor First Degree Battery (PC 784.03) in Pinellas County Court, Florida. Smith-Levin was charged with […]
Scientology OT8 Gary Cardone publicly stated that he was going through a “very violent divorce” in a public video. This would seem to act against his own interest. It also argues that […]
At age 80, Scientologist billionaire Bob Duggan still surfs. However, these days he and his 1960’s-era longboard are surrounded by sharks. Bob Duggan and his Summit Therapeutics (NASDAQ: SMMT) are simultaneously facing […]